Priority Review Vouchers For Pediatric Rare Disease: Will Popularity Force A Quick Halt?

Based on designations, FDA already could have enough products in the pipeline to trigger the mandatory program stop and assessment.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America